Kari Efferen
Senior Director & Head of Analytical Development Pfizer
Seminars
Wednesday 25th February 2026
Lessons Learned for Building Fast & Reliable Analytical Development Strategies from Early Research to Phase I
9:00 am
- Key learnings from accelerating analytical development during the COVID-19 vaccine era
- Establishing fit-for-purpose assays to enable rapid transition from research to clinical manufacturing
- Implementing flexible analytical frameworks to support novel mRNA modalities and vaccine programs
